首页|期刊导航|Pharmacoeconomics and Policy|Impacts of China’s National Volume-Based Procurement policy on the pharmaceutical industry:A systematic review

Impacts of China’s National Volume-Based Procurement policy on the pharmaceutical industry:A systematic review

Zheng Zhu Jiawei Zhang Chao Gong Li Yang

Pharmacoeconomics and Policy2025，Vol.1Issue(2)：P.63-72,10.

Pharmacoeconomics and Policy2025，Vol.1Issue(2)：P.63-72,10.DOI:10.1016/j.pharp.2025.06.003

Impacts of China’s National Volume-Based Procurement policy on the pharmaceutical industry:A systematic review

Zheng Zhu ¹Jiawei Zhang ¹Chao Gong ¹Li Yang¹

作者信息

1. Department of Health Policy and Management,School of Public Health,Peking University,Beijing,100191,China Beijing Institute for Health Development,Peking University,Beijing,100191,China
折叠

摘要

关键词

Chinese pharmaceutical market/National Volume-Based Procurement/Pharmaceutical innovation/Financial performance/Market concentration/Capital market

分类

管理科学

引用本文复制引用

Zheng Zhu,Jiawei Zhang,Chao Gong,Li Yang..Impacts of China’s National Volume-Based Procurement policy on the pharmaceutical industry:A systematic review[J].Pharmacoeconomics and Policy,2025,1(2):P.63-72,10.

基金项目

funded by the National Natural Science Foundation of China(Grant Nos.:72174010,71911530221,and 71673004). （Grant Nos.:72174010,71911530221,and 71673004）

Pharmacoeconomics and Policy

ISSN：2950-2667

访问量0

下载量0

段落导航